Globus Medical, Inc. (GMED)

Check out top investors' recommendation for GMED
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
58.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. It offers approximately 100 innovative fusion and disruptive technology products that address an array of spinal pathologies, anatomies, and surgical approaches. The company’s innovative fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Its disruptive technology products provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies. The company’s products under clinical development include SECURE-C Cervical Artificial Disc, an artificial disc designed to alleviate pain and preserve motion in patients with symptomatic cervical disc disease; ACADIA Facet Replacement System, which allows for an anatomic reconstruction of the facet joint after the degenerated facet is decompressed and removed; and TRIUMPH Lumbar Disc that is used in the treatment of lumbar degenerative disc disease. Globus Medical, Inc. sells its implants and related disposables primarily to hospitals. The company markets and sells its products through sales representatives and independent distributors in the United States and 17 countries internationally. Globus Medical, Inc. was founded in 2003 and is based in Audubon, Pennsylvania.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Matthew O'Brien William Blair & Company, L.L.C. Buy   Sep 13, '18     58.00  Sep 13, '19  N/A 
Michael Matson Mizuho Securities USA Buy   Aug 02, '18     65.00  Aug 02, '19  N/A 
Bob Hopkins BofA Merrill Lynch Sell   Jun 27, '18     55.00  Jun 27, '19  N/A 
Richard Newitter Leerink Swann Llc Buy   May 30, '18     61.00  May 30, '19  N/A 
Michael Matson Mizuho Securities USA Buy   Apr 04, '18       Apr 04, '19  N/A 
Richard Newitter Leerink Swann Llc Buy   Mar 28, '18     60.00  Mar 28, '19  N/A 
Matthew Taylor National Bank Financial Sell   Jan 09, '18     36.00  Jan 09, '19  N/A 
Larry Biegelsen Wells Fargo Securities, Llc Buy   Jan 05, '18       Jan 05, '19  N/A 
Matthew O'Brien William Blair & Company, L.L.C. Buy   Jan 02, '18     45.00  Jan 02, '19  N/A 
Larry Biegelsen Wells Fargo Securities, Llc Buy   Dec 04, '17     46.00  Dec 04, '18  N/A 
Matthew Taylor National Bank Financial Sell   Oct 19, '17     27.00  Oct 19, '18  N/A 
Matthew Taylor National Bank Financial Sell   Aug 03, '17     28.00  Aug 03, '18  N/A 
Matthew O'Brien William Blair & Company, L.L.C. Buy   Jul 18, '17     34.50  Jul 18, '18  N/A 
Richard Newitter Leerink Swann Llc Buy   May 18, '17       May 18, '18  N/A 
Matthew O'Brien William Blair & Company, L.L.C. Buy   May 17, '17       May 17, '18  N/A 
William Plovanic Canaccord Genuity Buy   May 04, '17     37.00  May 04, '18  N/A 
Richard Newitter Leerink Swann Llc Buy   Apr 12, '17       Apr 12, '18  N/A 
Richard Newitter Leerink Swann Llc Buy   Feb 25, '16   24.34  29.00  Feb 25, '17  17.91% 
David Turkaly JMP Securities Buy   Jan 07, '16   26.27  31.00  Jan 07, '17  -5.52% 
Richard Newitter Leerink Swann Llc Buy   Jan 07, '16   26.27  32.00  Jan 07, '17  -5.52% 
< previous123